Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach.
2 blocks of code here have a permanent identifier (oscr:b:…), listed with the matches below: citable for good, with a page of its own. Select a match and press Cite to copy it. What a block identifier is.
The 2 matches · all tie a paragraph to a whole file without given lines: weak matches, whose lines are not tinted
- [1] § Method details › Single-cell and single nuclei sequencing › Data processing and downstream analyses ↔ 01_validation_preprocessing.R, the whole file · a weak match · score 0.72 · Cell Ranger, SCTransform, Seurat, matrices, filtering, PCA · block
oscr:b:4DY63NBJ36NXY-H· Report a mismatch - [2] § Method details › Single-cell and single nuclei sequencing › Data processing and downstream analyses ↔ 03_annotation_and_signatures.R, the whole file · a weak match · score 0.71 · module scores, AddModuleScore, gene signatures, endothelial, validation · block
oscr:b:6BFPY48WN74C5-G· Report a mismatch
Paper
Loaded from Europe PMC by your browser; OSCR does not store it: doi.org · Europe PMC
The paper is loaded when this pane is shown.
The authors' code
R · 46 lines · 1.3 KB · no license · 1 match
- # 01_validation_preprocessing.R
- # Preprocess the validation snRNA-seq dataset generated in this study
- source("scripts/00_config.R")
- # Example: load Cell Ranger matrices
- sample_dirs <- list.dirs(file.path(data_dir, "validation_dataset"), recursive = FALSE)
- seurat_list <- list()
- for (s in sample_dirs) {
- sample_name <- basename(s)
- counts <- Read10X(file.path(s, "filtered_feature_bc_matrix"))
- obj <- CreateSeuratObject(
- counts = counts,
- project = sample_name,
- min.cells = 3,
- min.features = 200
- )
- obj$sample_id <- sample_name
- seurat_list[[sample_name]] <- obj
- }
- # Merge samples
- combined <- merge(seurat_list[[1]], y = seurat_list[-1])
- # QC metrics
- combined[["percent.mito"]] <- PercentageFeatureSet(combined, pattern = "^MT-")
- # Filtering example (adjust thresholds to match manuscript)
- combined <- subset(combined, subset =
- nFeature_RNA > 300 &
- nFeature_RNA < 8000 &
- percent.mito < 20)
- # Normalization and clustering
- combined <- SCTransform(combined, verbose = FALSE)
- combined <- RunPCA(combined)
- combined <- RunUMAP(combined, dims = 1:30)
- combined <- FindNeighbors(combined, dims = 1:30)
- combined <- FindClusters(combined, resolution = 0.5)
- saveRDS(combined, file.path(obj_dir, "validation_processed.rds"))
01_validation_preprocessing.R at commit 977d889, no license · at the source
Overview
15 affiliations
- Hopp Children’s Cancer Center Heidelberg (KiTZ),69120 Heidelberg, Germany
- Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ),Im Neuenheimer Feld 580, 69120 Heidelberg, Germany
- Faculty of Biosciences, Heidelberg University,Im Neuenheimer Feld 234, 69120 Heidelberg, Germany
- Department of Radiation Oncology, Heidelberg University Hospital,Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
- Clinical Cooperation Unit Radiation Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ),Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
- Internal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University, Medical Faculty Heidelberg / Heidelberg University Hospital,Im Neuenheimer Feld 410, 69120 Heidelberg, Germany
- Heidelberg Faculty of Medicine, Department of Pediatric Hematology, Oncology and Immunology, Heidelberg University Hospital,Im Neuenheimer Feld 430, 69120 Heidelberg, Germany
- Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ),Heidelberg, Germany
- Department of General Pediatrics, Hematology and Oncology, University Children’s Hospital Tuebingen,Tübingen, Germany
- University of Tuebingen, iFIT Cluster of ExCellence (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”,Tübingen, Germany
- German Cancer Research Consortium (DKTK), Partner Site Tuebingen, German Cancer Research Center (DKFZ),Heidelberg, Germany
- Division of Proteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ),Heidelberg, Germany
- Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK),69120 Heidelberg, Germany
- Princess Máxima Center for Pediatric Oncology and University Medical Center Utrecht (UMCU),Utrecht, The Netherlands
- National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital,69120 Heidelberg, Germany
Abstract
A significant obstacle in treating brain tumors is the limited drug penetration across the blood-brain barrier (BBB), characterized by an interplay of endothelial tight junctions and efflux pumps. Brain tumors can alter BBB characteristics; however, there is limited understanding in ependymoma (EPN), the third most common pediatric brain tumor. To this end, we characterized EPN tumor (n = 364) and healthy brain tissues (n = 225) at RNA level and identified a distinct EPN group-specific BBB transcriptional pattern. Analyses of public datasets from Aubin and Gojo as well as a validation single-cell dataset (n = 8) could further specify a novel BBB signature expressed in an endothelial subpopulation. Clinically relevant drugs (n = 3) that were effective against EPN in vitro were further evaluated for BBB penetration in our subtype-specific patient-derived xenograft (PDX) models. Idasanutlin showed overall low brain-to-plasma ratios, while the P-glycoprotein (PGP) substrates temsirolimus and etoposide accumulated slightly more in zinc finger translocation associated (ZFTA)-fusion positive EPN than in PFA tumors and adjacent brain. These differences align with modestly lower PGP levels in ZFTA PDX, although expression does not necessarily reflect transporter activity and was not consistently observed in patient tumors. Despite these differences, all tested drugs remained below their effective in vitro levels. In summary, multi-omics analyses of BBB characteristics improve the understanding of drug penetrance and may potentially guide treatment choices in the context of molecular EPN groups within upcoming clinical trials.
Supplementary Information: The online version contains supplementary material available at 10.1038/
Reproduced under the paper's license (CC BY), from the paper cited above.
Repository
Its files are read in the Code ↔ Paper reader above, with 2 matches between paragraphs and lines of code.
afederico-sci/scRNAseq_BBB_analysis
977d8892c54258c122619fa169161fd6da2fe9d1, 8 March 2026Availability: 1 check, the latest on 29 September 2026: the link answers
- 29 September 2026: the link answers
7 files
- 00_config.R, R, 27 lines
- 01_validation_preprocess
ing.R , R, 46 lines, 1 match - 02_reference_dataset_pro
cessing.R , R, 24 lines - 03_annotation_and_signat
ures.R , R, 22 lines, 1 match - 04_generate_figures.R, R, 16 lines
- 05_generate_tables.R, R, 14 lines
- README.md, Text, 12 lines
Code availability
Code for single cell analysis is available here: https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Tracing map
Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.
What the map holds:
- 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
- 6 scripts, each with its path and the digest of its content;
- 2 matches between paragraphs of the paper and lines of the code (method lexical-v1);
- neither the text of the paper nor the code itself.
Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.
Data
No dataset and no data link were found in the paper.
Data availability
Human RNA array data are publicly available (GEO: GSE64415 and GEO: GSE50161, GSE50385, GSE21687, GSE3526). All other data are available from the corresponding author upon request.
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 29 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 23 authors, 9 keywords, 10 MeSH terms, 1 funder, 71 references.
Cite
This paper
Sundheimer, J. K., Benzel, J., Federico, A., Volz, S., Knoll, M., Statz, B., Zheng, T., Kmiecik, S. W., Burhenne, J., Bajraktari-Sylejmani, G., Scheuermann, S., King, A., Müller, T., Hübner, J.-M., Kalxdorf, M., Peterziel, H., Oehme, I., Krijgsveld, J., Seitz, C. M., . . . Maaß, K. K. (2026). Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach. Scientific reports, 16(1), 12061. https://
BibTeX
@article{sundheimer2026e
author = {Sundheimer, Julia K. and Benzel, Julia and Federico, Aniello and Volz, Stefanie and Knoll, Maximilian and Statz, Britta and Zheng, Tuyu and Kmiecik, Szymon W. and Burhenne, Jürgen and Bajraktari-Sylejmani, Gzona and Scheuermann, Sophia and King, Anke and Müller, Torsten and Hübner, Jens-Martin and Kalxdorf, Mathias and Peterziel, Heike and Oehme, Ina and Krijgsveld, Jeroen and Seitz, Christian M. and Kool, Marcel and Pfister, Stefan M. and Pajtler, Kristian W. and Maaß, Kendra K.},
title = {{Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach}},
journal = {Scientific reports},
year = {2026},
month = apr,
volume = {16},
number = {1},
pages = {12061},
publisher = {Nature Publishing Group},
issn = {2045-2322},
doi = {10.1038/
url = {https://
pmid = {41963440},
pmcid = {PMC13070042}
}
RIS
TY - JOUR
AU - Sundheimer, Julia K.
AU - Benzel, Julia
AU - Federico, Aniello
AU - Volz, Stefanie
AU - Knoll, Maximilian
AU - Statz, Britta
AU - Zheng, Tuyu
AU - Kmiecik, Szymon W.
AU - Burhenne, Jürgen
AU - Bajraktari-Sylejmani, Gzona
AU - Scheuermann, Sophia
AU - King, Anke
AU - Müller, Torsten
AU - Hübner, Jens-Martin
AU - Kalxdorf, Mathias
AU - Peterziel, Heike
AU - Oehme, Ina
AU - Krijgsveld, Jeroen
AU - Seitz, Christian M.
AU - Kool, Marcel
AU - Pfister, Stefan M.
AU - Pajtler, Kristian W.
AU - Maaß, Kendra K.
TI - Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach
T2 - Scientific reports
J2 - Sci Rep
PY - 2026
DA - 2026/
VL - 16
IS - 1
SP - 12061
SN - 2045-2322
PB - Nature Publishing Group
DO - 10.1038/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1038/
"type": "article-journal",
"title": "Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach",
"container-title": "Scientific reports",
"author": [
{
"family": "Sundheimer",
"given": "Julia K."
},
{
"family": "Benzel",
"given": "Julia"
},
{
"family": "Federico",
"given": "Aniello"
},
{
"family": "Volz",
"given": "Stefanie"
},
{
"family": "Knoll",
"given": "Maximilian"
},
{
"family": "Statz",
"given": "Britta"
},
{
"family": "Zheng",
"given": "Tuyu"
},
{
"family": "Kmiecik",
"given": "Szymon W."
},
{
"family": "Burhenne",
"given": "Jürgen"
},
{
"family": "Bajraktari-Sylejmani",
"given": "Gzona"
},
{
"family": "Scheuermann",
"given": "Sophia"
},
{
"family": "King",
"given": "Anke"
},
{
"family": "Müller",
"given": "Torsten"
},
{
"family": "Hübner",
"given": "Jens-Martin"
},
{
"family": "Kalxdorf",
"given": "Mathias"
},
{
"family": "Peterziel",
"given": "Heike"
},
{
"family": "Oehme",
"given": "Ina"
},
{
"family": "Krijgsveld",
"given": "Jeroen"
},
{
"family": "Seitz",
"given": "Christian M."
},
{
"family": "Kool",
"given": "Marcel"
},
{
"family": "Pfister",
"given": "Stefan M."
},
{
"family": "Pajtler",
"given": "Kristian W."
},
{
"family": "Maaß",
"given": "Kendra K."
}
],
"container-title-short":
"volume": "16",
"issue": "1",
"page": "12061",
"DOI": "10.1038/
"PMID": "41963440",
"PMCID": "PMC13070042",
"ISSN": "2045-2322",
"publisher": "Nature Publishing Group",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
10
]
]
}
}
The tracing map gets a citation of its own once an author has validated it and it has a DOI.
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1158/0008-5472.can-24-1938 [code]
- Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid Tumors.Journal: Cancer researchIn common: ggplot2, tidyverse, genetics / omics, other condition, 4 references
- [2] doi:10.1038/s41467-023-38044-0 [code]
- 3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.Journal: Nature communicationsIn common: ggplot2, tidyverse, genetics / omics, other condition, cellular / molecular, 4 references
- [3] doi:10.1186/s13073-023-01185-4 [code]
- Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/
6 inhibition. Journal: Genome medicineIn common: Seurat, ggplot2, tidyverse, genetics / omics, other condition, mouse, 1 other category, 3 references - [4] doi:10.1093/neuonc/noaf179 [code]
- A cycling, progenitor-like cell population at the base of atypical teratoid rhabdoid tumor subtype differentiation trajectories.Journal: Neuro-oncologyIn common: Seurat, ggplot2, tidyverse, genetics / omics, other condition, 4 references
- [5] doi:10.1038/s41467-024-54547-w [code]
- Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instability.Journal: Nature communicationsIn common: Seurat, ggplot2, tidyverse, genetics / omics, other condition, 3 references
- [6] doi:10.1038/s41586-026-10214-2 [code]
- Multidimensional profiling of heterogeneity in supratentorial ependymomas.Journal: NatureIn common: Seurat, ggplot2, tidyverse, genetics / omics, other condition, mouse, 3 references
- [7] doi:10.1016/j.isci.2025.114564
- Preclinical drug screen identifies WEE1 inhibitor and vinca alkaloid as a combination treatment concept for Li-Fraumeni syndrome medulloblastoma.Journal: iScienceIn common: other condition, 5 references
- [8] doi:10.1126/sciadv.adr1481 [code]
- Modulation of blood-tumor barrier transcriptional programs improves intratumoral drug delivery and potentiates chemotherapy in GBM.Journal: Science advancesIn common: Seurat, ggplot2, tidyverse, other condition, mouse, cellular / molecular, 3 references
- [9] doi:10.1016/j.isci.2023.107585 [code]
- Multi-omic approach identifies hypoxic tumor-associated myeloid cells that drive immunobiology of high-risk pediatric ependymoma.Journal: iScienceIn common: Seurat, ggplot2, tidyverse, genetics / omics, other condition, cellular / molecular, 3 references
- [10] doi:10.1186/s40478-025-02024-w
- Ultra-low-input cell-free DNA sequencing for tumor detection and characterization in a real-world pediatric brain tumor cohort.Journal: Acta neuropathologica communicationsIn common: genetics / omics, other condition, 4 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Validate its tracing map
You validate the map as this page shows it: 1 repository of the authors' code, each at its verified commit and with its license, 6 scripts, and 2 matches between paragraphs and code (see the Code and Map sections). It then receives a DOI on Zenodo, with you (your ORCID iD) and OSCR as its creators; the code itself is not deposited.
The map's fingerprint: sha256:19e36a788c97101a…
Add the badge to the code's README
If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.
Markdown
<!-- oscr-badge:start -->
[](https://openscicode.org/badge/doi/10.1038/s41598-026-47499-2)
<!-- oscr-badge:end -->reStructuredText
.. oscr-badge:start
.. image:: https://openscicode.org/badge/doi/10.1038/s41598-026-47499-2.svg
:target: https://openscicode.org/badge/doi/10.1038/s41598-026-47499-2
:alt: OSCR
.. oscr-badge:endHTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1038/s41598-026-47499-2"><img src="https://openscicode.org/badge/doi/10.1038/s41598-026-47499-2.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->On GitHub, open the README, choose Edit (the pencil), paste the snippet under the title, then "Commit changes".
If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Report a mismatch between the code and the paper · Report a code error (signed in)
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Report a reproduction failure (signed in)
Versions of its code: the releases of its code tied to a version of this paper (the preprint, the accepted manuscript, the version of record…), each with the tracing map versioned with it.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
